Publication Type:

Journal Article

Source:

Cancer Letters, Volume 81, Number 2, p.171-175 (1994)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-0028352848&partnerID=40&md5=9942c9ab63d539c12f6d54b380f64497

Keywords:

2 (3 aminopropylamino)ethanethiol, animal, animal experiment, animal model, antineoplastic agent, article, cancer chemotherapy, controlled study, DNA damage, doxorubicin, drug toxicity, ehrlich ascites tumor, free radical, heart injury, Inbred BALB C, lipid peroxidation, liver injury, Lung injury, Mercaptoethylamines, Mice, mouse, nonhuman, priority journal, protective agent

Abstract:

<p>The protective effect of WR-1065 against the side effects of Adriamycin was studied in tumor bearing mice. It has been noticed that WR-1065 pretreatment improved the Adriamycin toxicities such as increased enzyme levels, pathological lesions in lung, liver and heart and increased rate of lipid peroxidation, without reducing its anticancer property. © 1994.</p>

Notes:

cited By 4

Cite this Research Publication

Dr. Damodaran Vasudevan, Bhanumathi, P., and Saleesh, E. D., “WR-1065 as a chemoprotector in Adriamycin chemotherapy”, Cancer Letters, vol. 81, pp. 171-175, 1994.

207
PROGRAMS
OFFERED
5
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS